Association of TIMP-1 and TIMP-2 gene polymorphisms with progression of liver fibrosis in patients with type C chronic liver disease

Biochemical Genetics

Volumn 51, Issue 7-8, 2013, Pages 564-574

  Ikebuchi, Yuichiro ^a   Ishida, Chihiro ^a   Okamoto, Kinya ^a   Murawaki, Yoshikazu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Genotype; Liver fibrosis; TIMP 1; TIMP 2

Indexed keywords

ALBUMIN; BILIRUBIN; GENOMIC DNA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALLELE; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; DISEASE COURSE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENOTYPE; HEPATITIS C VIRUS; HOMOZYGOTE; HUMAN; JAPANESE; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTHROMBIN TIME; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT; TIMP 1 GENE; TIMP 2 GENE;

AGED; ALLELES; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPATITIS C; HOMOZYGOTE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SERUM ALBUMIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

HEPATITIS C VIRUS;

EID: 84880598382     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-013-9587-8     Document Type: Article

References (31)

1. Arthur MJP (2000) Fibrogenesis II: metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279:G245-G249
2. Baker AH, Edwards DR, Murphy G (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115:3719-3727
3. Bekkaoui F, Poisson I, Crosby W, Cloney L, Duck P (1996) Cycling probe technology with RNase H attached to an oligonucleotide. Biotechniques 20:240-248
4. Bernardo MM, Fridman R (2003) TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J 374:739-745
5. De Clerck YA, Darville MI, Eeckhout Y, Rousseau GG (1994) Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinase-2 (TIMP-2). Gene 139:185-191
6. Duck P, Alvarado-Urbina G, Burdick B, Collier B (1990) Probe amplifier system based on chimeric cycling oligonucleotides. Biotechniques 9:142-148
7. Faisst S, Meyer S (1992) Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 20:3-26
8. Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, Bruguera M, Sánchez-Tapias JM, Rodés J (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36:986-992
9. Friedman SL (2003) Liver fibrosis: from bench to bedside. J Hepatol 38:S38-S53
10. Hegab AE, Sakamoto T, Uchida Y, Nomura A, Ishii Y, Morishima Y, Mochizuki M, Kimura T, Saitoh W, Iizuka T, Kiwamoto T, Sekizawa K (2005) Promoter activity of human tissue inhibitor of metalloproteinase 2 gene with novel single nucleotide polymorphisms. Respirology 10:27-30
11. Hemmann S, Graf J, Roderfeld M, Roeb E (2007) Expression of MMPs and TIMPs in liver fibrosis: a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 46:955-975
12. Hinterseher I, Krex D, Kuhlisch E, Schmidt KG, Pilarsky C, Schneiders W, Pilarsky C, Schneiders W, Saeger HD, Bergert H (2007) Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm. World J Surg 31:2248-2254
13. Hirano K, Sakamoto T, Uchida Y, Morishima Y, Masuyama K, Ishii Y, Nomura A, Ohtsuka M, Sekizawa K (2001) Tissue inhibitor of metalloproteinases-2 gene polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 18:748-752
14. Indelicato M, Chiarenza V, Libra M, Malaponte G, Bevelacqua V, Marchini M, McCubrey JA, Stivala F, Scorza R, Mazzarino MC (2006) Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients. J Clin Lab Anal 20:173-176
15. Kang S, Zhao X, Xing H, Wang N, Zhou R, Chen S, Li W, Zhao J, Duan Y, Sun D, Li Y (2008) Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis. Environ Mol Mutagen 49:226-231
16. Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y (2007) FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 45:297-306
17. Krex D, Röhl H, König IR, Ziegler A, Schackert HK, Schackert G (2003) Tissue inhibitor of metalloproteinases-1, -2 and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 34:2817-2821
18. Marcellin P (2009) Hepatitis B and hepatitis C in 2009. Liver Int 29:S1-S8
19. Marcellin P, Asselah T, Boyer N (2002) Fibrosis and disease progression in hepatitis C. Hepatology 36:S47-S56
20. Meijer MJW, Mieremet-Ooms MAC, van Hogezand RA, Lamers CBHW, Hommes DW, Verspaget HW (2007) Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol 13:2960-2966
21. Murawaki Y, Ikuta Y, Idobe Y, Kitamura Y, Kawasaki H (1997) Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease. J Hepatol 26:1213-1219
22. Murawaki Y, Ikuta Y, Kawasaki H (1999) Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1. Clin Chim Acta 281:109-120
23. Nie Q-H, Zhu C-L, Zhang Y-F, Yang J, Zhang J-C, Gao R-T (2010) Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis. Dig Dis Sci 55:1286-1295
24. O-charoenrat P, Khantapura P (2006) The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol 42:257-267
25. Polette M, Birembaut P (1998) Membrane-type metalloproteinases in tumor invasion. Int J Biochem Cell Biol 30:1195-1202
26. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C: the ObsVirC, MetaVir, CliniVir, and DosVirC groups. Lancet 349:825-832
27. Promrat K, McDermott DH, Gonzalez CM, Kleiner DE, Koziol DE, Lessie M, Merrell M, Soza A, Heller T, Ghany M, Park Y, Alter HJ, Hoofnagle JH, Murphy PM, Liang TJ (2003) Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124:352-360
28. Wei JC, Lee HS, Chen WC, Shiu LJ, Yang SF, Wong RH (2009) Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis. Ann Rheum Dis 68:1781-1786
29. Wei S, Chen Y, Chung L, Nagase H, Brew K (2003) Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. J Biol Chem 278:9831-9834
30. Yi YC, Chen M-K, Chen L-Y, Ho ES-C, Ying T-H, Wang P-H, Yang SF (2009) Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer. Clin Chim Acta 409:127-131
31. Zhou Y, Yu C, Miao X, Tan W, Liang G, Xiong P, Sun T, Lin D (2004) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25:399-404